HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stacey A Strong Selected Research

aflibercept

1/2020Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosa.
5/2016Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stacey A Strong Research Topics

Disease

3Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2020 - 05/2016
1Macular Degeneration (Age-Related Maculopathy)
01/2023
1Retinal Perforations
01/2019
1Epiretinal Membrane (Epiretinal Membranes)
01/2019

Drug/Important Bio-Agent (IBA)

2afliberceptIBA
01/2020 - 05/2016
1UK 1IBA
01/2023
1Indicators and Reagents (Reagents)IBA
01/2023
1Carbonic Anhydrase InhibitorsIBA
01/2019
1Ranibizumab (Lucentis)FDA Link
05/2016

Therapy/Procedure

1Traction
01/2019
1Intravitreal Injections
05/2016